Bill

Bill > A3328


NJ A3328

NJ A3328
Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill prohibits the sale of certain items which use advertisements linked or alluding to controlled dangerous substances or analogs. The bill bans the sale of any food, beverage, or other product meant to be ingested or inhaled which uses the advertisement on its packaging or elsewhere. The bill further prohibits the sale of any product using the advertising, regardless of the product's intended use, to a person under 18 years of age. The bill specifies that the provisions do not apply to any prescription medication dispensed by a pharmacist pursuant to a valid prescription. A violation under the bill would be an unlawful practice under the consumer fraud act, which is punishable by a monetary penalty of not more than $10,000 for a first offense and not more than $20,000 for any subsequent offense. Additionally, a violation can result in a cease and desist order issued by the Attorney General, the assessment of punitive damages, and the awarding of treble damages and costs to the injured.

AI Summary

This bill prohibits the sale of certain products that use advertisements, either on their packaging or elsewhere, which directly or indirectly reference or allude to controlled dangerous substances, which are illegal drugs, or their analogs, which are substances with similar chemical structures and effects. Specifically, it bans the sale of any food, beverage, or other product intended for ingestion or inhalation if its advertising makes such references, and it also prohibits the sale of any product, regardless of its intended use, to individuals under 18 years of age if its advertising alludes to controlled dangerous substances or their analogs. Importantly, this prohibition does not apply to prescription medications dispensed by a pharmacist with a valid prescription. Violations are considered unlawful practices under the consumer fraud act, leading to penalties such as monetary fines of up to $10,000 for a first offense and up to $20,000 for subsequent offenses, along with potential cease and desist orders from the Attorney General, punitive damages, and treble damages and costs awarded to those harmed.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced, Referred to Assembly Consumer Affairs Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...